This paper is in the following e-collection/theme issue:

Infectious Diseases (non-STD/STI) (1674) Public (e)Health, Digital Epidemiology and Public Health Informatics (889) Cross-Sectional Studies in Public Health (367) Vaccination and Immunization in the Digital Age (413) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1537) Outbreak and Pandemic Preparedness and Management (1793) COVID-19 Vaccination (170)

Published on in Vol 10 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/57242, first published .
COVID-19 Vaccine Preferences in General Populations in Canada, Germany, the United Kingdom, and the United States: Discrete Choice Experiment

COVID-19 Vaccine Preferences in General Populations in Canada, Germany, the United Kingdom, and the United States: Discrete Choice Experiment

COVID-19 Vaccine Preferences in General Populations in Canada, Germany, the United Kingdom, and the United States: Discrete Choice Experiment

Authors of this article:

David Salisbury1 Author Orcid Image ;   Jeffrey V Lazarus2, 3 Author Orcid Image ;   Nancy Waite4 Author Orcid Image ;   Clara Lehmann5 Author Orcid Image ;   Sumitra Sri Bhashyam6 Author Orcid Image ;   Marie de la Cruz7 Author Orcid Image ;   Beth Hahn8 Author Orcid Image ;   Matthew D Rousculp8 Author Orcid Image ;   Paolo Bonanni9 Author Orcid Image
Article Authors Cited by (2) Tweetations Metrics

Journals

  1. Áñez G, McGarry A, Woo W, Kotloff K, Gay C, Zhu M, Cloney-Clark S, Nelson J, Dunbar H, Cai M, Cho I, Cai Z, Kalkeri R, Plested J, Patel N, Smith K, Marchese A, Glenn G, Mallory R, Dunkle L. Safety and immunogenicity of four sequential doses of NVX-CoV2373 in adults and adolescents: A phase 3, randomized, placebo-controlled trial (PREVENT-19). Vaccine 2025;61:127362 View
  2. Hinzpeter E, Kairies-Schwarz N, Beaudart C, Douxfils J, Nayak D, Hiligsmann M. A Systematic Review of Discrete Choice Experiments on Preferences for COVID-19 Vaccinations. The Patient - Patient-Centered Outcomes Research 2025 View